Genmab — November 2020
-
Sælg lidt over 2500 https://www.proinvestor.com/boards/88701/Genmab-retracement#88742
-
a bit more on IL-8 https://twitter.com/follow_5/status/1326351269775118336/photo/1
-
Servicemeddelelse: Vi har fået en chat for IPOs.
-
God morgen.
-
Mandagens danske avisuddrag med S&P, Codan og Danske Bankhttps://www.proinvestor.com/investornyt/669824/mandagens-danske-avisuddrag-med-sp-codan-og-danske-bank
-
Ses vi. Velkommen til Online Investormøde med tre Nasdaq selskaber!
Online Investormøde med Green Mobility, Monsenso og Konsolidator.
Vi glæder os til at byde dig velkommen til et spændende og informativt investormøde med tre lovende børsnoterede virksomheder! https://www.proinvestor.com/index.php?p=debat_1&postid=88772
-
Spørgsmål til Q&A er meget velkommen.
-
Yuhan gets $65m from Janssen for lazertinib milestone achievement http://www.koreaherald.com/view.php?ud=20201123000807
-
Development of [ 89 Zr]ZrDFO-amivantamab bispecific to EGFR and c-MET for PET imaging of triple-negative breast cancer https://pubmed.ncbi.nlm.nih.gov/32770372/ -> could this imply breast cancer is a possible next target for amivantamab?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind